## EFX: Equifax, Inc. - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.3% in lower entry zone (3.0-6.0%), top quartile (82nd pct) cross-sectional ranking. Short-term MRS_5 (1.0%) confirms momentum alignment. Strong momentum (+2.2% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($207.88)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Lazard Asset Management LLC Buys 140,427 Shares of Equifax, Inc. $EFX**
- Source: MarketBeat | 20251214T134158 | Neutral | Relevance: 99%
- Lazard Asset Management LLC increased its stake in Equifax (NYSE:EFX) by 8.9% in Q2, acquiring 140,427 additional shares, bringing its total holdings to 1,726,990 shares valued at approximately $447.9 million. This move comes as several insiders, including CEO Mark W. Begor and EVP Jamil Farshchi, have sold shares, though analysts maintain a "Moderate Buy" rating with a consensus target price of $276.40. Equifax reported strong Q3 earnings, beating estimates, and declared a quarterly dividend of $0.50.

**2. Veriskâ€“KYND Cyber Data Tie-Up Might Change The Case For Investing In Verisk Analytics (VRSK)**
- Source: Simply Wall Street | 20251214T193851 | Neutral | Relevance: 64%
- Verisk's expanded collaboration with KYND integrates KYND's cyber risk intelligence into Verisk's Rulebook platform, aiming to strengthen Verisk's cyber offering for insurers. This partnership addresses the increasing demand for advanced cyber risk data, potentially influencing Verisk's long-term growth and product differentiation by deepening its role in insurers' workflows. However, the impact on Verisk's revenue will depend on how quickly insurance clients adopt these analytics services, especially after a period of softer revenue.

**3. Verisk Analytics (VRSK) Valuation After Q3 Revenue Miss, Outlook Cut and Expanded KYND Cyber Partnership**
- Source: Simply Wall Street | 20251216T122504 | Neutral | Relevance: 56%
- Verisk Analytics (VRSK) is facing mixed signals after missing Q3 revenue expectations and cutting its full-year outlook, despite expanding its KYND cyber partnership. While its share price is suffering near-term, long-term faith seems intact, with the stock trading below intrinsic estimates and analyst targets. Investors are now evaluating whether this presents a mispriced opportunity or if the market is accurately discounting future growth.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 9.9% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +2.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.02 suggests fair value with growth premium. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.9B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.02 |
| Forward P/E | 24.7 |
| Current P/E | 28.7 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.1% to 3.3% (+2.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 1.0% confirms short-term momentum alignment. Below SMA200 (0.90x), long-term trend not supportive. MACD histogram positive (1.67), confirming momentum. RSI neutral at 56. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.33% (CS: 83) | Strong |
| RSI_14 | 56.3 | Neutral |
| MACD Histogram | 1.67 | Bullish |
| vs SMA20 | 1.031x | Above |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 0.901x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $218.60
- **Stop Loss:** $207.88 (4.9% risk)
- **Target:** $234.68 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 111
- **Position Value:** $24,264.60
- **Portfolio %:** 24.26%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*